Uncovering behind-the-scenes challenges in bringing gene therapies to market
Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.
Read MoreClinically Speaking: Gene Therapies: Million-Dollar Miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read MoreHow to have a data-driven discussion on gene and cellular therapies
As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.
Read MoreHelping plans and patients get life-changing gene therapies
Gene therapies offer hope where none existed before, but health plans and employers need the right strategy to make these cutting-edge medications affordable and available.
Read MoreInnovation in hemophilia drug development and cost-efficiency tools
As treatment for hemophilia evolves, data proves a good specialty pharmacy partner can help minimize waste and drive efficient practices.
Read MoreThree specialty drug trends to prepare for: Biosimilars, gene and cell therapies, cancer drugs
Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...
Read MoreTwo Ways to Assess the Holistic Value of Your Specialty Partner
Getting the most value out of your specialty drug management partner starts with asking the right questions.
Read MoreCopay Assistance Strategy Reduces Financial Burdens for Plans And Patients
Innovative solution provides $0 member cost for costly specialty drugs while reducing plans’ costs
Read More